Poly Medicure Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Poly Medicure Share Price

1,516.805.90 (0.40%)

Closed
As On: 16 Jun, 2026, 04:01 PM IST
As On: 16 Jun, 2026, 03:42 PM IST

Sector: Hospitals & All...
Industry: Medical Equipment ...

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	1,524.70
High	1,531.70
Low	1,498.00
Prev Close	1,510.90
Volume	38,561
VWAP(₹)	1,515.63

Key Metrics

PE Ratio(x)	47.73
EPS - TTM(₹)	31.78
MCap(₹ Cr.)	15,374.21
MCap Rank	10
PB Ratio(x)	4.86
Div Yield(%)	0.23
Face Value(₹)	5.00
52W High(₹)	2,316.60
52W Low(₹)	1,182.00
MCap/Sales	6.44
Beta(1 Month)	-0.14
BV/Share(₹)	310.70

Poly Medicure share price insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 21.45% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Candle Formations Yesterday
Black Spinning Top was formed for Poly Medicure
Stock Screener Highlights
Poly Medicure is a part of Mid-cap Growth Stocks Screener
Decrease in Cash from Investing
Company has used Rs 225.38 cr for investing activities which is an YoY decrease of 81.13%. (Source: Consolidated Financials)
Poly Medicure Share Price Update
Poly Medicure Ltd. share price moved up by 0.40% from its previous close of Rs 1,510.90. Poly Medicure Ltd. stock last traded price is 1,516.80
Share Price Value
Today/Current/Last 1,516.801,512.20
Previous Day 1,510.901,512.45

Found Insights useful?

Poly Medicure Share Price Returns

1 Day	0.4%
1 Month	1.19%
3 Months	20.8%
1 Year	-30.92%
3 Years	32.32%
5 Years	60.75%

Poly Medicure Share Recommendations

Mean recosCurrent

HOLD

5 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	1	1	2	2
Buy	1	1	1	1
Hold	2	2	2	2
Sell	1	1	-	-
Strong Sell	-	-	-	-
# Analysts	5	5	5	5

Recent Recos

Target₹1035
OrganizationHDFC Securities
BUY

Target₹925
OrganizationICICI Securities
BUY

View all Stock Recommendations

News & Analysis

View all Poly Medicure Share News & Announcements

Financials

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	519.92	477.83	444.90	465.14	446.01
Total Income Growth (%)	8.81	7.40	-4.35	4.29	-0.02
Total Expenses	418.03	354.13	320.33	342.40	331.18
Total Expenses Growth (%)	18.05	10.55	-6.44	3.39	1.97
EBIT	101.89	123.70	124.57	122.74	114.83
EBIT Growth (%)	-17.63	-0.70	1.49	6.89	-5.35
Profit after Tax (PAT)	70.93	91.84	93.08	91.83	85.23
PAT Growth (%)	-22.76	-1.34	1.36	7.75	-2.55
EBIT Margin (%)	19.60	25.89	28.00	26.39	25.75
Net Profit Margin (%)	13.64	19.22	20.92	19.74	19.11
Basic EPS (₹)	7.00	9.06	9.19	8.92	8.48

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	448.41	450.26	425.14	444.92	432.68
Total Income Growth (%)	-0.41	5.91	-4.44	2.83	0.69
Total Expenses	338.46	329.47	305.26	326.26	316.17
Total Expenses Growth (%)	2.73	7.93	-6.43	3.19	2.10
EBIT	109.96	120.79	119.88	118.66	116.52
EBIT Growth (%)	-8.97	0.76	1.02	1.84	-2.95
Profit after Tax (PAT)	78.38	89.05	87.93	86.66	85.15
PAT Growth (%)	-11.98	1.28	1.46	1.77	-2.37
EBIT Margin (%)	24.52	26.83	28.20	26.67	26.93
Net Profit Margin (%)	17.48	19.78	20.68	19.48	19.68
Basic EPS (₹)	7.73	8.79	8.68	8.40	8.48

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,758.96	1,434.54	1,151.42	960.97	804.88
Total Revenue Growth (%)	22.61	24.59	19.82	19.39	14.05
Total Expenses	1,311.62	1,092.80	915.85	768.17	628.14
Total Expenses Growth (%)	20.02	19.32	19.23	22.29	7.91
Profit after Tax (PAT)	338.56	258.26	179.28	146.51	135.87
PAT Growth (%)	31.09	44.05	22.37	7.82	41.72
Operating Profit Margin (%)	27.50	25.66	21.91	21.34	23.55
Net Profit Margin (%)	20.27	18.77	16.07	15.87	17.27
Basic EPS (₹)	34.13	26.92	18.69	15.28	15.25

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,691.57	1,365.43	1,104.33	918.09	766.67
Total Revenue Growth (%)	23.89	23.64	20.29	19.75	15.33
Total Expenses	1,248.68	1,030.53	867.51	723.37	593.29
Total Expenses Growth (%)	21.17	18.79	19.93	21.93	9.27
Profit after Tax (PAT)	331.33	251.72	179.04	146.02	129.51
PAT Growth (%)	31.63	40.59	22.62	12.74	40.19
Operating Profit Margin (%)	28.36	26.43	22.95	22.55	24.25
Net Profit Margin (%)	20.68	19.25	16.76	16.60	17.32
Basic EPS (₹)	33.40	26.24	18.67	15.23	14.54

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 21.45% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	3,192.45	1,858.67	1,577.21	1,376.83	1,223.73
Total Assets Growth (%)	71.76	17.85	14.55	12.51	59.48
Total Liabilities	426.79	388.62	335.58	289.35	258.16
Total Liabilities Growth (%)	9.82	15.80	15.98	12.08	-22.36
Total Equity	2,765.66	1,470.05	1,241.63	1,087.48	965.57
Total Equity Growth (%)	88.13	18.40	14.17	12.63	122.06
Current Ratio (x)	5.18	2.40	2.75	3.46	4.12
Total Debt to Equity (x)	0.06	0.12	0.12	0.12	0.11
Contingent Liabilities	293.55	229.96	163.99	169.58	99.20

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	3,140.36	1,821.35	1,537.76	1,333.96	1,187.41
Total Assets Growth (%)	72.42	18.44	15.28	12.34	60.47
Total Liabilities	396.14	363.10	303.64	256.99	233.40
Total Liabilities Growth (%)	9.10	19.58	18.15	10.11	-24.87
Total Equity	2,744.22	1,458.25	1,234.12	1,076.97	954.01
Total Equity Growth (%)	88.19	18.16	14.59	12.89	122.23
Current Ratio (x)	5.44	2.42	2.81	3.65	4.44
Total Debt to Equity (x)	0.06	0.11	0.11	0.10	0.10
Contingent Liabilities	356.97	229.96	163.99	169.58	99.20

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	240.42	266.08	190.83	123.47	118.73
Net Cash used in Investing Activities	-1,194.28	-240.94	-179.02	-85.33	-435.58
Net Cash flow from Financing Activities	950.51	-20.15	-12.51	-35.34	316.95
Net Cash Flow	-3.35	4.99	-0.70	2.80	0.10
Closing Cash & Cash Equivalent	8.70	12.05	7.06	7.76	4.95
Closing Cash & Cash Equivalent Growth (%)	-27.83	70.67	-8.96	56.57	2.00
Total Debt/ CFO (x)	0.74	0.64	0.77	1.01	0.86

Annual	FY 2025	FY 2024	FY 2022	FY 2022	FY 2021
Net Cash flow from Operating Activities	236.65	256.10	126.26	194.86	116.40
Net Cash used in Investing Activities	-1,191.17	-237.02	-88.71	-187.22	-434.41
Net Cash flow from Financing Activities	952.93	-17.32	-39.71	-7.89	318.92
Net Cash Flow	-1.59	1.76	-2.16	-0.25	0.90
Closing Cash & Cash Equivalent	0.55	2.14	0.63	0.38	2.79
Closing Cash & Cash Equivalent Growth (%)	-74.41	459.99	-77.34	-39.57	47.51
Total Debt/ CFO (x)	0.72	0.63	0.87	0.69	0.78

All figures in Rs Cr, unless mentioned otherwise

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 240.69 cr is 0.75 times compared to the reported net profit of Rs 322.14 cr. (Source: Consolidated Financials)
Decrease in Cash from Investing
Company has used Rs 225.38 cr for investing activities which is an YoY decrease of 81.13%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	12.24	17.56	14.43	13.47	14.07
Return on Capital Employed (%)	16.27	23.42	19.03	17.13	17.60
Return on Assets (%)	10.60	13.89	11.36	10.64	11.10
Interest Coverage Ratio (x)	45.18	36.90	34.12	58.99	21.76
Asset Turnover Ratio (x)	0.66	0.80	0.73	0.69	64.26
Price to Earnings (x)	67.11	59.17	51.02	62.11	57.80
Price to Book (x)	8.21	10.37	7.36	8.37	8.12
EV/EBITDA (x)	41.97	36.62	30.20	36.69	33.99
EBITDA Margin (%)	32.45	30.30	27.04	27.19	29.59

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	12.07	17.26	14.50	13.55	13.57
Return on Capital Employed (%)	16.23	23.13	19.31	17.53	17.50
Return on Assets (%)	10.55	13.82	11.64	10.94	10.90
Interest Coverage Ratio (x)	46.91	37.96	36.23	69.55	22.91
Asset Turnover Ratio (x)	0.65	0.78	0.74	0.70	62.94
Price to Earnings (x)	68.97	60.61	51.28	62.50	60.61
Price to Book (x)	8.28	10.46	7.41	8.45	8.22
EV/EBITDA (x)	42.50	37.46	30.26	36.67	34.72
EBITDA Margin (%)	33.40	31.18	28.16	28.52	30.45

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
44%
Positive Movement
since 1st Jan 2005
on basis
55%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 1533.00 Pivot
1515.50
S1 1499.30
R2 1549.20 S2 1481.80
R3 1582.90 S3 1448.10
Average True Range
5 Days 14 Days 28 Days
62.68 67.56 66.35

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Poly Medicure	47.73	4.88	10.37	13.36	8.22	19.89	23.83	16.80	31.79	3.37	0.11	1.42
Nureca Ltd	109.21	1.26	1.15	3.43	1.06	9.30	4.26	1.41	2.11	8.32	0.00	0.22
Add More

Annual Ratios (%)

Choose from Peers

Choose from Stocks

Stock Performance
- CHART
- TABLE
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
- Choose from Peers
  Choose from Stocks
NAME 1D 1W 1M 3M 1Y 3Y 5Y
Poly Medicure Stock Performance 0.40 -0.28 2.45 20.78 -39.08 56.06 33.86
Nureca Ltd Stock Performance 1.17 -12.11 -7.81 -18.30 -5.10 -27.21 -84.93
Add More
All values in %
Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 6,32,65,340 62.42 % 0.00
Pledge 0 0.00 % 0.00
FII 59,91,354 5.92 % -3.49
DII 1,58,04,134 15.60 % 1.75
MF 89,56,792 8.84 % 0.69
Others 1,62,98,662 16.06 % 1.73
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 62.42 62.42 62.42 62.44
Pledge 0.00 0.00 0.00 0.00
FII 5.92 9.41 9.77 11.41
DII 15.60 13.84 13.53 11.72
Mutual Funds 8.84 8.14 8.04 7.34
Others 16.06 14.32 14.28 14.43

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Quant Small Cap Direct-G
Equity: Small Cap
3
- 588.07
  Amount Invested (in Cr.)
- 1.850794%
  % of AUM
- 0.00
  % Change (MoM basis)
UTI Flexi Cap Direct-G
Equity: Flexi Cap
1
- 188.96
  Amount Invested (in Cr.)
- 0.84931116%
  % of AUM
- 0.00
  % Change (MoM basis)
SBI Healthcare Opportunities Direct-G
Equity: Sectoral-Pharma
5
- 86.38
  Amount Invested (in Cr.)
- 1.89%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Poly Medicure Top Searches

Corporate Actions

Recent
Final
70%
May 25, 2026
Board Meeting
Audited Results & Final Dividend
May 14, 2026
Board Meeting
Quarterly Results
Jan 29, 2026

Announced on	Meeting on
May 14, 2026	May 25, 2026
Audited Results & Final Dividend
Jan 29, 2026	Feb 05, 2026
Quarterly Results
Oct 31, 2025	Nov 08, 2025
Quarterly Results
Jul 29, 2025	Aug 08, 2025
Quarterly Results & Others
Apr 29, 2025	May 06, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 06, 2025 Sep 18, 2025 70%
May 17, 2024 Sep 19, 2024 60%
May 09, 2023 Sep 21, 2023 60%
May 24, 2022 Sep 16, 2022 50%
May 25, 2026 - 70%

Announced on	Ex-Date
Feb 06, 2017	Mar 24, 2017
Bonus Ratio: 1 share(s) for every 1 shares held
May 13, 2013	Jul 09, 2013
Bonus Ratio: 1 share(s) for every 1 shares held
Feb 09, 2010	Mar 26, 2010
Bonus Ratio: 1 share(s) for every 1 shares held

Splits
Announced on Ex-Date
Nov 05, 2014 Feb 02, 2015
Split: Old FV10.0| New FV:5.0
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Sep 04, 2025 Sep 25, 2025
-
Jul 04, 2025 Aug 05, 2025
-
Dec 24, 2024 Jan 25, 2025
-
Sep 10, 2024 Sep 26, 2024
Rs.3.0000 per share(60%)Final Dividend & A.G.M.
Jul 04, 2024 Aug 05, 2024
-

About Poly Medicure

Poly Medicure Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 15,374.21 Crore) operating in Hospitals & Allied Services sector.

Poly Medicure Ltd. key Products/Revenue Segments include Medical Equipments & Accessories, Export Incentives, Scrap for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 552.27 Crore, up 6.22 % from last quarter Total Income of Rs 519.92 Crore and up 18.73 % from last year same quarter Total Income of Rs 465.14 Crore. Company has reported net profit after tax of Rs 63.33 Crore in latest quarter.

The company’s top management includes Mr.Devendra Raj Mehta, Mr.Himanshu Baid, Mr.Rishi Baid, Mr.Vishal Baid, Mr.Alessandro Balboni, Mr.Jugal Kishore Baid, Dr.Ambrish Mithal, Mr.Amit Khosla, Ms.Sonal Mattoo, Mr.Vimal Bhandari, Mr.Vishal Gupta, Mr.Pankaj Kumar Gupta, Mr.Naresh Vijayvergiya, Mr.Avinash Chandra, Mr.Ravi Prakash. Company has M C Bhandari & Co. as its auditors. As on 31-03-2026, the company has a total of 10.14 Crore shares outstanding.

Poly Medicure Share Price Today is Rs. 1516.80. On previous day, the Poly Medicure Share Price (NSE) closed at Rs. 1532.4, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 62.42% of the stake in Poly Medicure shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Poly Medicure stocks was 5.92% as compared to 9.41% in Dec 2025 with decrease of 3.49%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 15.6% as compared to 13.84% in Dec 2025 with increase of 1.76%. Out of the total DII holdings in Poly Medicure shares 8.84% was held by mutual funds. The rest including public held is 16.06%. Poly Medicure stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Poly Medicure Dividend: Ever since 1995, Poly Medicure dividends has been paid out around 26 times. As on 16 Jun, 2026, 04:01 PM IST, The overall dividend yield for Poly Medicure stands at 0.23%. The last dividend paid was on September 18, 2025 (Rs. 3.5). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 31.78.

Poly Medicure Bonus: The most recent bonus issue had been in year March 24, 2017 around 9 years ago at 1 : 1 ratio. The first bonus issue was announced in Feb 2010.

Stock Forecast:
After showing 552.27 Cr. of sales and 6.22% of quarterly net profit, there have been multiple ups and downs in the Poly Medicure stock prices in the past few weeks. For example, Poly Medicure stock price on 8th of June 2026 was around Rs. 1382.8. Poly Medicure share price now stands at an average of Rs. 1516.80. Judging by last week's performance, stock is in up trend.

Poly Medicure has a median target price of Rs. 1648.6 in 12 months by 5 analysts. They have provided a high estimate of Rs. 2050.0 and low estimate of Rs. 1365.0 for Poly Medicure share.

Historical Prices and Performance:
Poly Medicure, incorporated in 1995 is a Mid Cap company (with a market cap of Rs. 15314.41) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Poly Medicure stock was 10.37%, 12.24%, 17.56%, 14.43% and 13.47% respectively.
The Poly Medicure share gave a 3 year return of 34.13% as compared to Nifty 50 which gave a return of 27.64%.
Poly Medicure announced 70.0% final dividend on September 18, 2025.

Key Metrics:
PE Ratio of Poly Medicure is 48.22
Prices/Sales Ratio of Poly Medicure is 6.44
Price/Book Ratio of Poly Medicure is 4.93

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Poly Medicure, major competitors and peers include Nureca Ltd. As of Dec 2025, the dividend yield of Poly Medicure stands at 0.23% while Nureca Ltd stand at 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 48.22 and 4.93 respectively.

Recommendations:
The current total number of analysts covering the stock stands at 5, Three months ago this number stood at 5. Out of total, 1 analyst have a'Strong Buy' reco, 1 analyst have a'Buy' reco, 2 analyst have a'Hold' reco, 1 analyst have a'Sell' reco.

Mean recommendations by 5 analyst stand at'Buy'.

Leadership of Poly Medicure :
Avinash Chandra is Co. Secretary & Compl. Officer
Ravi Prakash is Deputy Company Secretary
Naresh Vijayvergiya is Chief Financial Officer
Devendra Raj Mehta is Chairman (Non - Executive) & Non Independent Direc
Himanshu Baid is Managing Director
Rishi Baid is Joint Managing Director
Vishal Baid is Executive Director
Jugal Kishore Baid is Non Exe.Non Ind.Director
Alessandro Balboni is Non Exe.Non Ind.Director
Ambrish Mithal is Ind. Non-Executive Director
Vimal Bhandari is Ind. Non-Executive Director
Amit Khosla is Ind. Non-Executive Director
Sonal Mattoo is Ind. Non-Executive Director
Vishal Gupta is Ind. Non-Executive Director
Pankaj Kumar Gupta is Additional Executive Director

Show More

Industry

Medical Equipment & Accessories

Key Indices Listed On

Nifty 500, BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare

Address

No. 232-B, 3rd Floor,Okhla Industrial Estate,New Delhi, Delhi - 110020

Contact

investorcare@polymedicure.com

http://www.polymedicure.com

Executive Leadership

DR

Devendra Raj Mehta

Chairman (Non - Executive) & Non Independent Direc

HB

Himanshu Baid

Managing Director

RB

Rishi Baid

Joint Managing Director

VB

Vishal Baid

Executive Director

Show More

Auditors

Doogar & Associates

M C Bhandari & Co.

FAQs about Poly Medicure share

1. What's the Poly Medicure share price today?
Poly Medicure share price is Rs 1,516.80 as on 16 Jun, 2026, 04:01 PM IST. Poly Medicure share price is up by 0.40% based on previous share price of Rs. 1532.4.
2. What's the market capitalization of Poly Medicure?
Within the Hospitals & Allied Services sector, Poly Medicure stock has a market cap rank of 10. Poly Medicure has a market cap of Rs 15,374.21 Cr.
3. What is Poly Medicure's 52 week high / low?
52 Week high of Poly Medicure share is Rs 2,316.60 while 52 week low is Rs 1,182.00
4. What are the returns for Poly Medicure share?
Return Performance of Poly Medicure Shares:
- 1 Week: Poly Medicure share price moved up by 3.98%
5. What is the PE & PB ratio of Poly Medicure?
The PE ratio of Poly Medicure stands at 47.54, while the PB ratio is 4.86.

Top Gainers

As on 03:59 PM | 16 Jun 2026

Sonata Software

311.25

50.90 (19.56%)

997.80

91.75 (10.13%)

75.74

5.55 (7.91%)

PG Electroplast

527.45

34.66 (7.04%)

Century Texttiles

1,315.70

75.71 (6.11%)

Top Losers

As on 04:01 PM | 16 Jun 2026

358.40

-28.86 (-7.45%)

17,809.00

-847.00 (-4.55%)

366.65

-15.71 (-4.11%)

Akums Drugs & Pharma

596.85

-23.11 (-3.73%)

1,089.50

-36.21 (-3.22%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.